# Assessment of Safety and Immunogenicity of R21/Matrix-M™ in African Children Living With HIV

> **NCT05385510** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 122 (actual)

## Conditions studied

- Malaria

## Interventions

- **BIOLOGICAL:** R21/Matrix-M™

## Key facts

- **NCT ID:** NCT05385510
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-10
- **Primary completion:** 2025-09-03
- **Final completion:** 2025-09-03
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05385510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05385510, "Assessment of Safety and Immunogenicity of R21/Matrix-M™ in African Children Living With HIV". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05385510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*